Tuesday, September 10, 2013

Health News: [diabetes ]: ChemoCentryx Falls on Weak Diabetic Nephropathy Drug Data

Yahoo! Health   |  My alerts   |   Edit Alert
Tuesday, Sep 10, 2013 12:11 PM EDT
 
   Health News : diabetes - News from other sources.
 
ChemoCentryx Falls on Weak Diabetic Nephropathy Drug Data
Tue, 10 Sep, 2013 09:10 AM PDT
MOUNTAIN VIEW, Calif. (TheStreet) -- An experimental ChemoCentryx drug designed to treat kidney damage caused by diabetes doesn't appear to be working very well, according to an interim analysis of an mid-stage study announced Tuesday. ChemoCentryx intends to continue the diabetic nephropathy drug stud...
Continue reading
NY school district says no to diabetes service dog
Tue, 10 Sep, 2013 09:06 AM PDT
HENRIETTA, N.Y.—An upstate New York district is refusing to allow a diabetic 11-year-old to bring a dog trained to sniff out blood sugar swings
Continue reading
NY School District Says No to Diabetes Service Dog
Tue, 10 Sep, 2013 09:05 AM PDT
Western NY district says no to diabetic student's request to bring service dog to school        
Continue reading
Rush Henrietta Central School District says no to diabetes service dog
Tue, 10 Sep, 2013 09:03 AM PDT
A diabetic 11-year-old whose family paid $20,000 for a dog trained to sniff out blood sugar swings at school is being tutored at home after the upstate New York district refused to allow the animal in class.
Continue reading
NY School District Says No to Diabetes Service Dog
Tue, 10 Sep, 2013 08:59 AM PDT
Western NY district says no to diabetic student's request to bring service dog to school        
Continue reading
NY school district says no to diabetes service dog
Tue, 10 Sep, 2013 08:59 AM PDT
HENRIETTA, N.Y. (AP) - A diabetic 11-year-old whose family paid $20,000 for a dog trained to sniff out blood sugar swings at school is being tutored at home after the upstate New York district refused to allow the animal in class.
Continue reading
Intestinal tube prototype aims to become a parmanent answer to obesity
Tue, 10 Sep, 2013 08:04 AM PDT
MetaboShield, is an innovative intestinal sleeve that can be lodged permanently in the small intestine via the throat in an anesthesia-free procedure. Though it is still a prototype, when developed the sleeve could help people shed unwanted pounds and potentially help reverse type 2 diabetes... Continu...
Continue reading
Drs. Oz and Roizen July 15
Tue, 10 Sep, 2013 08:02 AM PDT
Inflammation interferes with your body's ability to use blood sugar for fuel — raising glucose levels to dangerous heights. If you've already been diagnosed with diabetes, gum disease makes it more difficult to get your blood sugar down into a normal range, raising your risk for complications like athe...
Continue reading
5 Percent Of US Children Are 'Severely Obese,' New Risk Category Rising Among Youth
Tue, 10 Sep, 2013 08:01 AM PDT
While childhood obesity may be leveling off, a new class of obesity has grown in prevalence, according to the American Heart Association. Severe obesity -- a newly defined class of risk -- exists in 5 percent of all U.S. children . Effective treatment options are limited to these children who are at a high ri...
Continue reading
Novo's Sales Assault on U.S. Diabetes Market Sets Rivalry
Tue, 10 Sep, 2013 07:48 AM PDT
Drugmakers led by Novo Nordisk A/S (NOVOB) and Merck & Co. (MRK) are increasing sales efforts for their top-selling diabetes drugs to grab as much of the market as possible ahead of a wave of new therapies.
Continue reading
You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment